AMRX PDUFA decision: a positive outcome, +6.0%

On February 24, 2025, Amneal Pharmaceuticals, Inc. reached its PDUFA decision. The result was a positive outcome, and the stock moved +6.0% in the window around the event. It had already run -9.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.